Oruka Therapeutics, Inc. (ORKA)Healthcare | Biotechnology | Menlo Park, United States | NasdaqGM
68.92 USD
+1.85
(2.758%)
⇧
(April 17, 2026, 4 p.m.
EDT)
After hours: 69.97 +1.05 (1.524%) ⇧ (April 17, 2026, 7:44 p.m. EDT) Short-term: ★★★★☆ | Long-term: ★☆☆☆☆ | Dividends: ★★☆☆☆ |
Hot Take | April 18, 2026, 11:39 p.m. EDT
ORKA is a textbook 'technically broken, fundamentally speculative' play. While the chart shows a massive comeback from the $9 lows (up nearly 8x), the fundamentals don't support this; negative cash flow and R&D heavyburn with no current revenue make the long-term hold a 0-star trap for value. However, the short-term chart momentum is undeniable, backed by the strongest analyst consensus ever ('Strong Buy' and upgrades), causing intelligent money to pile in calls anticipating a move toward analyst targets before the inevitable second-half volatility reversal. |
| Model | MAE |
|---|---|
| AutoTheta ✓ | 0.173684 |
| AutoARIMA | 0.191332 |
| AutoETS | 0.191658 |
| MSTL | 0.194196 |
Forecast horizon: 45 days | Selected: AutoTheta
| Forecast Reliability | |
|---|---|
| Score | 32% |
| H-stat | 35.11 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.027 |
| Excess Kurtosis | -0.54 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Last Dividend Date | 2024-08-28 |
| Debt to Equity Ratio | 0.409 |
| Market Cap | 3,414,482,176 |
| Forward P/E | -25.86 |
| Website | https://orukatx.com |
As of April 18, 2026, 11:39 p.m. EDT: Options activity shows aggressive bullish positioning on calls near the target price of $82 (ATM), particularly with new flow into the $60 ITM calls. Puts remain heavily skewed toward deep OTM strikes (35-45), suggesting a 'bet on the ground' strategy or hedging against a potential drop to the 52-week low rather than active selling. The massive imbalance in OI (Open Interest) favoring the upside relative to the current price indicates a 'long gamma' sentiment theme where speculators profit from rapid moves, despite the company's negative cash flow.
| Date | Dividend | Yield % |
|---|---|---|
| 2024-08-29 | 19.356 | 64.52 |
| Attribute | Value |
|---|---|
| 52 Week Change | 6.410753 |
| Address1 | 855 Oak Grove Avenue |
| Address2 | Suite 100 |
| All Time High | 75,932,640.0 |
| All Time Low | 5.49 |
| Ask | 70.37 |
| Ask Size | 13 |
| Audit Risk | 5 |
| Average Analyst Rating | 1.2 - Strong Buy |
| Average Daily Volume10 Day | 1,398,410 |
| Average Daily Volume3 Month | 708,211 |
| Average Volume | 708,211 |
| Average Volume10Days | 1,398,410 |
| Bid | 68.83 |
| Bid Size | 13 |
| Board Risk | 4 |
| Book Value | 9.626 |
| City | Menlo Park |
| Compensation As Of Epoch Date | 1,735,603,200 |
| Compensation Risk | 9 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 68.92 |
| Current Ratio | 22.366 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,774,915,200 |
| Day High | 70.0 |
| Day Low | 66.7965 |
| Debt To Equity | 0.409 |
| Display Name | Oruka Therapeutics |
| Dividend Date | 1,724,803,200 |
| Earnings Timestamp End | 1,778,702,400 |
| Earnings Timestamp Start | 1,778,702,400 |
| Ebitda | -121,968,000 |
| Ebitda Margins | 0.0 |
| Enterprise To Ebitda | -25.271 |
| Enterprise Value | 3,082,301,184 |
| Eps Current Year | -2.21734 |
| Eps Forward | -2.6656 |
| Eps Trailing Twelve Months | -1.85 |
| Esg Populated | 0 |
| Exchange | NGM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 42.3784 |
| Fifty Day Average Change | 26.5416 |
| Fifty Day Average Change Percent | 0.6263002 |
| Fifty Two Week Change Percent | 641.07526 |
| Fifty Two Week High | 70.14 |
| Fifty Two Week High Change | -1.2200012 |
| Fifty Two Week High Change Percent | -0.017393801 |
| Fifty Two Week Low | 8.91 |
| Fifty Two Week Low Change | 60.01 |
| Fifty Two Week Low Change Percent | 6.735129 |
| Fifty Two Week Range | 8.91 - 70.14 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 871,047,000,000 |
| Float Shares | 37,565,250 |
| Forward Eps | -2.6656 |
| Forward P E | -25.855341 |
| Free Cashflow | -55,834,876 |
| Full Exchange Name | NasdaqGM |
| Full Time Employees | 68 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Governance Epoch Date | 1,775,001,600 |
| Gross Margins | 0.0 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.03489 |
| Held Percent Institutions | 1.0883499 |
| Implied Shares Outstanding | 49,542,691 |
| Industry | Biotechnology |
| Industry Disp | Biotechnology |
| Industry Key | biotechnology |
| Ir Website | http://phx.corporate-ir.net/phoenix.zhtml?c=109749&p=irol-irhome |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Dividend Date | 1,724,889,600 |
| Last Dividend Value | 19.356 |
| Last Fiscal Year End | 1,767,139,200 |
| Last Split Date | 1,725,321,600 |
| Last Split Factor | 1:12 |
| Long Business Summary | Oruka Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing novel monoclonal antibody therapeutics for psoriasis (PsO), and other inflammatory and immunology (I&I) indications. Its lead products include ORKA-001 that targets p19 subunit of interleukin-23, which is in phase 2a trial for the treatment of PsO; and ORKA-002 that targets interleukin-17A and interleukin-17F, which is in phase 2 trial for the treatment of PsO, psoriatic arthritis, and other conditions. The company also develops ORKA-003 for targeting an undisclosed pathway; and ORKA-021, a sequential combination regimen of ORKA-002 and ORKA-001. Oruka Therapeutics, Inc. is headquartered in Menlo Park, California. |
| Long Name | Oruka Therapeutics, Inc. |
| Market | us_market |
| Market Cap | 3,414,482,176 |
| Market State | CLOSED |
| Max Age | 86,400 |
| Message Board Id | finmb_1877171755 |
| Most Recent Quarter | 1,767,139,200 |
| Net Income To Common | -84,310,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 3,412,995,982 |
| Number Of Analyst Opinions | 12 |
| Open | 68.52 |
| Operating Cashflow | -88,210,000 |
| Operating Margins | 0.0 |
| Overall Risk | 7 |
| Payout Ratio | 0.0 |
| Phone | 650 606 7910 |
| Post Market Change | 1.050003 |
| Post Market Change Percent | 1.52351 |
| Post Market Price | 69.97 |
| Post Market Time | 1,776,469,457 |
| Previous Close | 67.07 |
| Price Eps Current Year | -31.082287 |
| Price Hint | 2 |
| Price To Book | 7.1597753 |
| Profit Margins | 0.0 |
| Quick Ratio | 21.923 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | strong_buy |
| Recommendation Mean | 1.15385 |
| Region | US |
| Regular Market Change | 1.85 |
| Regular Market Change Percent | 2.75831 |
| Regular Market Day High | 70.0 |
| Regular Market Day Low | 66.7965 |
| Regular Market Day Range | 66.7965 - 70.0 |
| Regular Market Open | 68.52 |
| Regular Market Previous Close | 67.07 |
| Regular Market Price | 68.92 |
| Regular Market Time | 1,776,456,000 |
| Regular Market Volume | 1,379,385 |
| Return On Assets | -0.17246 |
| Return On Equity | -0.24687 |
| Sand P52 Week Change | 0.38150132 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Share Holder Rights Risk | 8 |
| Shares Outstanding | 49,542,691 |
| Shares Percent Shares Out | 0.0913 |
| Shares Short | 4,522,980 |
| Shares Short Previous Month Date | 1,772,150,400 |
| Shares Short Prior Month | 4,466,793 |
| Short Name | Oruka Therapeutics, Inc. |
| Short Percent Of Float | 0.1275 |
| Short Ratio | 6.25 |
| Source Interval | 15 |
| State | CA |
| Symbol | ORKA |
| Target High Price | 125.0 |
| Target Low Price | 45.0 |
| Target Mean Price | 82.08333 |
| Target Median Price | 76.5 |
| Total Cash | 337,044,000 |
| Total Cash Per Share | 6.803 |
| Total Debt | 1,932,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -1.85 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 27.8792 |
| Two Hundred Day Average Change | 41.0408 |
| Two Hundred Day Average Change Percent | 1.4720938 |
| Type Disp | Equity |
| Volume | 1,379,385 |
| Website | https://orukatx.com |
| Zip | 94,025 |